Eli Lilly and Co (NYSE:LLY)
| 142.35 Delayed Data As of 4:00pm ET |  +0.70 / +0.49%Today’s Change | 101.36 Today|||52-Week Range 170.75 | +8.31% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 141.65 |
| Today’s open | 142.03 |
| Day’s range | 142.00 - 144.70 |
| Volume | 2,427,462 |
| Average volume (3 months) | 3,189,858 |
| Market cap | $139.8B |
Data as of 4:00pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | +58.64% |
| Earnings growth (this year) | +20.66% |
| Earnings growth (next 5 years) | +13.80% |
| Revenue growth (last year) | -9.11% |
| P/E ratio | 23.2 |
| Price/Sales | 5.51 |
| Price/Book | 53.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.04 | +0.08% |
| BMYBristol-Myers Squibb | -0.63 | -1.04% |
| NVONovo Nordisk | -0.13 | -0.18% |
| SNYSanofi | +0.35 | +0.72% |
Data as of 5:46pm ET, 10/23/2020
Financials
| Next reporting date | October 27, 2020 |
| EPS forecast (this quarter) | $1.71 |
| Annual revenue (last year) | $22.3B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 20.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
